[Experiences with the normophasic ovulation inhibitor Ovanon].
Nadjafi
C
C
D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003278:Contraceptives, Oral, Hormonal; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D008234:Lynestrenol; D008599:Menstruation Disturbances; D008656:Mestranol; D012106:Research
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003278:Contraceptives, Oral, Hormonal; D008656:Mestranol; D008234:Lynestrenol
Clinical Research; Contraception; Contraceptive Agents, Estrogen--side effects; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Contraceptive Effectiveness; Family Planning; Lynestrenol--side effects; Menstruation Disorders; Mestranol--side effects; Research Methodology; Use-effectiveness